Answers are grounded in this paper and cite their sources.
Our results show that a proteochemometric approach can provide generalized susceptibility predictions for new inhibitors. Our proteochemometric model can directly analyze inhibitor-protease interactions and facilitate treatment selection based on viral genotype. The model is available for public use, and is located at HIV Drug Research Centre.
No takes yet. Share an insight, caveat, or question.
Lapins et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: